Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer

NCT00313248 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
65
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer